Frontlight ResearchEarly access
Taking peopleNo phase
Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses.
Key facts
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 1 Oct 2024
- Expected to end
- 31 Oct 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Circulating microRNAs.
- Record updated
- 21 October 2024
Who can take part
- Age
- 18 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age >= 18 years
- Single testicular lesion, with < 2 cm diameter and < 30 % testicular volume involvement
- Negative Serum Tumour Markers
- Suitable for testis sparing surgery
- Informed consent
- Age >= 18 years
- Single/multiple post-chemotherapy retroperitoneal lymph node lesion, with > 1 cm (non seminomatous) / > 3 cm (seminomatous) diameter in patients with previous testicular germ cell primary tumour
- Negative Serum Tumour Markers
- Suitable for retroperitoneal lymph node dissection
- Informed consent
Who cannot take part
- None; COHORT B:
- None
Other criteria
- COHORT A:
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the diagnostic performance of circulating microRNAs in detecting the presence of germ cell cancer in patients with small testicular mass or retroperitoneal post-chemotherapy residual mass and suitable for testis sparing surgery and retroperitoneal lymph node dissection, respectively.
The 2 groups in the trial
- A
Small testicular mass suitable for testis sparing surgery.
Treatment: Circulating microRNAs.
- B
Retroperitoneal post-chemotherapy residual mass suitable for retroperitoneal lymph node dissection.
Treatment: Circulating microRNAs.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Diagnostic Role of Circulating microRNAs in Small Testicular Masses Suitable for Testis Sparing Surgery and Post-chemotherapy Residual Masses Suitable for Retroperitoneal Lymph Node Dissection.
- Record updated
- 21 October 2024